Clinical Trials Browser

Terminated × Interventional × Hepatitis C × Clear all

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

NCT01821963 2020-09-24

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Phase 3 Terminated

1 enrolled 3 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Infections

NCT02717949 2019-01-08

Optimal

Phase 4 Terminated

1 enrolled

Lymphoid

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

NCT00165633 2008-12-09

A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma

Phase 2/3 Terminated

540 enrolled

Gastrointestinal

Carcinoma, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Recurrence

Clinical Trials

MHALT

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Optimal

A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma